CUROME BIOSCIENCES

About CUROME BIOSCIENCES

The startup develops mitochondrial drugs targeting metabolic and intractable inflammatory diseases, focusing on rare conditions with significant unmet medical needs. By utilizing a differentiated research and development platform, the company aims to provide effective treatments that enhance the quality of life for patients suffering from these diseases.

The startup develops mitochondrial drugs targeting metabolic and intractable inflammatory diseases, focusing on rare conditions with significant unmet medical needs. By utilizing a differentiated research and development platform, the company aims to provide effective treatments that enhance the quality of life for patients suffering from these diseases.

What does CUROME BIOSCIENCES do?

The startup develops mitochondrial drugs targeting metabolic and intractable inflammatory diseases, focusing on rare conditions with significant unmet medical needs. By utilizing a differentiated research and development platform, the company aims to provide effective treatments that enhance the quality of life for patients suffering from these diseases.

Where is CUROME BIOSCIENCES located?

CUROME BIOSCIENCES is based in 청주시, 대한민국.

When was CUROME BIOSCIENCES founded?

CUROME BIOSCIENCES was founded in 2017.

How much funding has CUROME BIOSCIENCES raised?

CUROME BIOSCIENCES has raised $5.4M.

Location
청주시, 대한민국
Founded
2017
Funding
$5.4M
Employees
4 employees
Investors
Lagunai
CB

CUROME BIOSCIENCES

The startup develops mitochondrial drugs targeting metabolic and intractable inflammatory diseases, focusing on rare conditions with significant unmet medical needs. By utilizing a differentiated research and development platform, the company aims to provide effective treatments that enhance the quality of life for patients suffering from these diseases.

청주시, 대한민국Founded 2017410+ followers4/10 TractionRelative Traction Score based on online presence metrics compared to companies in the same age group.
Updated 18 months ago

Funding

$5.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

QV
Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

  • The startup develops mitochondrial drugs targeting metabolic and intractable inflammatory diseases, focusing on rare conditions with significant unmet medical needs. By utilizing a differentiated research and development platform, the company aims to provide effective treatments that enhance the quality of life for patients suffering from these diseases.
This profile is AI-generated and may contain inaccuracies.